MedTrace Logo

Levosimendan Administration and Outcome in Cardiac Surgery

NCT02275013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2014-10-27

No results posted yet for this study

Summary

To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.

Conditions

  • Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery

Interventions

DRUG

Levosimendan

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275013 on ClinicalTrials.gov